Drugs with this side effect as MedDRA Preferred Term
- 17-hydroxyprogesterone
- Injection site reaction: postmarketing
- 2-hydroxysuccinaldehyde
- Injection site reaction: postmarketing
- 5-azacytidine
- Injection site reaction: very common, 0% - 29.1%
- AMD3100
- Injection site reaction: 0% - 34%
- Anidulafungin
- BCNU
- Bivalirudin
- Injection site reaction: postmarketing
- EACA
- Enfuvirtide
- Eptifibatide
- FK463
- Fe(III
- Injection site reaction: 33%
- Forteo
- Injection site reaction: postmarketing
- Gd-DTPA
- Gd-EOB-DTPA
- Glat copolymer
- Goserelin
- Hoe 140
- Humalog
- ICI 182,780
- Injection site reaction: postmarketing
- Implanon
- Insulin
- Injection site reaction: common
- K779
- Injection site reaction: 23% - 35%
- LY146032
- Injection site reaction: 5.8% - 7.7%
- Lantus
- Leuprorelin
- Injection site reaction: postmarketing, 9%
- Lyxumia
- Meropenem anhydrous
- Metrodin
- Injection site reaction: postmarketing, very common, 4% - 6.67%
- NovoLog
- Octreotide
- Optison
- Org 37462
- PGE1
- Refludan
- SOM230
- Injection site reaction: 17.1% - 17.5%
- SU5416
- Signifor
- Injection site reaction: 17.1% - 17.5%
- SonoVue
- Supremon
- Injection site reaction: 5.4% - 11.9%
- Symlin
- Injection site reaction: postmarketing
- Triptorelin
- Injection site reaction: 3%
- acetaminophen
- Injection site reaction: 2.67% - 14.7%
- adenosine
- Injection site reaction: postmarketing
- allopurinol
- amiodarone
- Injection site reaction: postmarketing
- amobarbital
- amphotericin B
- amsacrine
- apomorphine
- arginine
- aripiprazole
- atosiban
- atropine
- benzathine penicillin
- bicalutamide
- boceprevir
- bortezomib
- buprenorphine
- capecitabine
- carboplatin
- carnitine
- Injection site reaction: 27% - 38%
- celecoxib
- cetrorelix
- choline
- cidofovir
- ciprofloxacin
- cladribine
- Injection site reaction: very common, 9% - 19%
- copolymer 1
- Injection site reaction: 6.5%
- cyclizine
- cyproterone
- cyproterone acetate
- cytarabine
- cytokinin
- dalteparin
- dantrolene
- Injection site reaction: postmarketing
- deferoxamine
- Injection site reaction: uncommon, very common
- degarelix
- demethyl
- dexrazoxane
- dextrorphan
- diazepam
- diclofenac
- Injection site reaction: common
- dicyclomine
- Injection site reaction: postmarketing
- diethylenetriaminepentaacetic acid
- diltiazem
- dipyridamole
- docetaxel
- Injection site reaction: 6%
- doxorubicin
- Injection site reaction: 2-20%
- ecallantide
- Injection site reaction: 3% - 7%
- exenatide
- Injection site reaction: postmarketing, common
- fenoldopam
- ferumoxytol
- Injection site reaction: postmarketing
- florbetaben
- florbetapir
- Injection site reaction: uncommon, 0.5%
- flumazenil
- fosphenytoin
- Injection site reaction: frequent
- gadobenate dimeglumine
- Injection site reaction: postmarketing
- gadodiamide
- gadolinium
- Injection site reaction: postmarketing, 0.3% - 1.53%
- gadopentetate
- Injection site reaction: postmarketing
- gadoteridol
- gadoversetamide
- Injection site reaction: 0.962% - 3.04%
- ganciclovir
- gatifloxacin
- gemcitabine
- Injection site reaction: postmarketing, 4%
- glutamine
- Injection site reaction: 0% - 25%
- glycopyrrolate
- gonadorelin
- Injection site reaction: common, 3.39% - 4.65%
- haloperidol
- hepatitis B vaccines
- Injection site reaction: common
- histamine
- hydromorphone
- Injection site reaction: postmarketing
- hydroxocobalamin
- ibandronate
- ibuprofen
- insulin detemir
- Injection site reaction: 0.6% - 1.7%
- iodixanol
- iohexol
- iopromide
- iron sucrose
- ketorolac tromethamine
- Injection site reaction: postmarketing
- lanreotide
- Injection site reaction: postmarketing
- lansoprazole
- Injection site reaction: 1%
- leuprorelin acetate
- Injection site reaction: 8.16% - 37.5%
- liraglutide
- Injection site reaction: postmarketing
- lorazepam
- Injection site reaction: infrequent, 0.769%
- mTHPC
- Injection site reaction: common
- medroxyprogesterone
- Injection site reaction: 5%
- medroxyprogesterone acetate
- Injection site reaction: 5%
- melphalan
- Injection site reaction: 50%
- meropenem
- mesna
- Injection site reaction: postmarketing, 6.7% - 10%
- methylene blue
- methylnaltrexone
- Injection site reaction: common
- methylprednisolone sodium succinate
- mipomersen
- Injection site reaction: 5% - 84%
- mitomycin C
- mivacurium
- moxifloxacin
- Injection site reaction: 1%
- mycophenolate mofetil
- nalbuphine
- naloxone
- naltrexone
- Injection site reaction: 3%
- nicardipine
- Injection site reaction: 1.4%
- ofloxacin
- olanzapine
- omeprazole
- Injection site reaction: 1.7% - 4.27%
- ondansetron
- Injection site reaction: common, 3.84%
- oxaliplatin
- Injection site reaction: very common, 0% - 11.1%
- oxymorphone
- paclitaxel
- Injection site reaction: postmarketing, rare, common, very common, 1% - 13%
- paliperidone
- palonosetron
- Injection site reaction: postmarketing
- pantoprazole
- parecoxib
- pegaptanib
- penicillin
- pentobarbital
- phenobarbital
- phentolamine
- phenytoin
- Injection site reaction: frequent
- piperacillin
- Injection site reaction: uncommon
- pregabalin
- Injection site reaction: rare
- promethazine
- prostacyclin
- rabeprazole
- radium
- rasburicase
- retinoic acid
- Injection site reaction: 17%
- ribavirin
- Injection site reaction: very common, 5% - 59%
- riluzole
- Injection site reaction: infrequent
- risperidone
- Injection site reaction: postmarketing, infrequent
- ropivacaine
- Injection site reaction: 0.2% - 2.1%
- salmon calcitonin acetate
- Injection site reaction: rare, uncommon
- secobarbital
- sodium ferric gluconate
- Injection site reaction: 33%
- sumatriptan
- Injection site reaction: 59%
- technetium-99m
- teduglutide
- Injection site reaction: 21%
- tesamorelin
- Injection site reaction: 1.3% - 4.6%
- testosterone
- Injection site reaction: postmarketing
- testosterone undecanoate
- tigecycline
- Injection site reaction: postmarketing, uncommon, common
- trabectedin
- triamcinolone acetonide
- ustekinumab
- Injection site reaction: uncommon
- valproate
- vecuronium
- verteporfin
- vinflunine
- vinorelbine
- Injection site reaction: 0% - 38%
- vitamin K
- voriconazole
- Injection site reaction: common
- x M22
- zoledronic acid
- Injection site reaction: uncommon
- zuclopenthixol
|